TAT-cyclo-CLLFVY TP2046
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1_, but not HIF-2_, with HIF-1_ (IC50 = 1.3 _M). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cance
CAS nr:
1446322-66-2
Purity:
98%
Molecular Weight:
2559,1
SMILES:
Formula:
C111H188N42O24S2
Pathway:
Target:
